Description
PULFIBRO 534 mg Capsule contains Pirfenidone 534 mg, a medication used to treat Idiopathic Pulmonary Fibrosis (IPF) — a progressive lung disease characterized by the thickening and scarring (fibrosis) of lung tissue. Pirfenidone slows disease progression by reducing inflammation and fibrosis in the lungs, helping patients maintain breathing capacity and lung function over time.
This higher-strength formulation is part of a stepwise dosing regimen and allows for convenient administration in fewer capsules as the dose increases during treatment.
 200ML.webp)
 150GM.webp)
 200 ML.jpeg)
 200ML.jpg)
 100ML.png)
 200ML.webp)
 50ML.webp)
60 ML 60 ML.webp)
 20ML.jpeg)
 250 ML.jpeg)
.webp)
 15ML.webp)
 30 TAB.webp)
.webp)
 125ML.jpg)
 40 ML.png)
 125ML.webp)
Change Language